Indications: This combination of Empagliflozin, Linagliptin, and Metformin is used to control blood sugar levels in adults with Type 2 Diabetes. It helps when diet and exercise alone are not enough.
Empagliflozin removes extra sugar through urine.
Linagliptin helps the body release more insulin.
Metformin reduces sugar production in the liver and improves insulin use.
Dosage:
Usually taken once or twice daily with food.
A common starting dose is 10mg/5mg/500mg or 1000mg.
The maximum daily dose is Empagliflozin 25 mg, Linagliptin 5 mg, and Metformin 2000 mg.
The doctor may adjust the dose based on kidney function and how well the medicine is working.
Avoid use in patients with severe kidney disease, liver impairment, or heart failure. Not recommended for Type 1 diabetes or diabetic ketoacidosis. Contraindicated in patients with a history of serious hypersensitivity reactions to any of the components. Metformin should not be used in cases of metabolic acidosis or severe dehydration.
Precautions
Avoid use in patients with severe kidney disease, liver impairment, or heart failure. Not recommended for Type 1 diabetes or diabetic ketoacidosis. Contraindicated in patients with a history of serious hypersensitivity reactions to any of the components. Metformin should not be used in cases of metabolic acidosis or severe dehydration.